Attending Biotech and Pharma
Bioregion Partners
Why attend BOS non clinical?
• Network with your peers from international biotech & pharma discovery and early development.
• Exchange ideas and transfer knowledge with regards to successful outsourcing.
• Hear from leading authorities in key areas of non clinical outsourcing
• Organise 1:1 meetings with leading discovery and early development vendors & industry consultants.
Welcome to the Biotech Outsourcing Strategies series of forums organised and run by Bio2Business Ltd (www.bio2business.com). BOS is the evolution of an ongoing 4 year project by Bio2Business Ltd to facilitate R&D outsourcing and partnering for international biotech and pharmaceutical companies.
A Day of Partnering & Networking
BOS is primarily a partnering event; a forum to connect international biotech & pharma outsourcing executives with a network of specialist CROs. BOS2008 has a clear focus on small molecule drug discovery/development. As a delegate attending BOS in London you can expect to meet with a significant number of top quality niche global CROs at the discovery/development interface who offer high quality, reliable services. You will be able to organise 1 to 1 meetings with CROs, consultants and fellow development executives as you wish throughout the day using Bio2Business partnering software. Informal networking over coffee, lunch and closing drinks receptions will give you an ideal opportunity to make links with fellow discovery/development executives and exchange ideas and approaches to outsourcing.
Speaker Programme
In addition to providing a partnering forum for discovery and development attendees, BOS also strives to deliver an outstanding programme of speakers to deliver perspective and approaches in the field of drug discovery & development. This year we are pleased to announce a first class programme of speakers including; Dr Julie Warneck, Head of Preclinical Research, Serentis Pharma Ltd; Dr Ming- Qiang Zhang, Senior VP of Research & Development, Biotica Technology Ltd; Dr Paul Little, Senior Chemist, 7TM Pharma A/S; Dr Maria Marlow, Team Leader Early Development Division, AstraZeneca; Dr Lloyd Payne, CSO, F2G Ltd.
Our speakers are international experts in their areas of specialisation including discovery biology and pharmacology, medicinal chemistry, development chemistry and preformulation. We believe such a blend of speakers talking about critical area's of discovery and early development will give a unique perspective on current approaches to biotech R&D outsourcing.
Key Sponsors
Gold CRO Sponsors
Silver CRO Sponsor
Corporate Sponsor
